Dragør, Denmark

Dorthe Da Graca Couto Thrige

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ascelia Pharma Ab. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dorthe Da Graca Couto Thrige: Innovator in MRI Technology

Introduction

Dorthe Da Graca Couto Thrige is a notable inventor based in Dragør, Denmark. She has made significant contributions to the field of medical technology, particularly in magnetic resonance imaging (MRI). Her innovative work has the potential to enhance diagnostic procedures and improve patient outcomes.

Latest Patents

Dorthe holds a patent for a "Compressed solid composition for MRI." This invention involves a physiologically acceptable manganese (II) compound, which is used to prepare an oral solution. The patent represents a significant advancement in MRI technology, offering new possibilities for imaging techniques.

Career Highlights

Dorthe is currently associated with Ascelia Pharma AB, a company dedicated to developing innovative solutions for medical imaging. Her work at Ascelia Pharma has allowed her to focus on creating effective and safe compositions for MRI applications. With her expertise, she has contributed to the advancement of medical imaging technologies.

Collaborations

Dorthe has collaborated with notable colleagues, including Bent Højgaard and Magnus Olafsson Corfitzen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical technology.

Conclusion

Dorthe Da Graca Couto Thrige is a pioneering inventor whose work in MRI technology is making a significant impact in the medical field. Her contributions are paving the way for advancements that can improve diagnostic capabilities and patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…